Qiming Venture Partners
Qiming Venture Partners is a global venture capital firm founded in 2006, investing in technology and healthcare companies at early and growth stages with a long-term, research-driven approach.
Qiming Venture Partners is a venture capital firm with a strong global reputation, recognized by investors worldwide for its consistent investment performance. Since its founding in 2006, the firm has built a diversified platform that supports high-potential companies across the technology and healthcare sectors, earning broad recognition from both institutional investors and entrepreneurs.
The firm currently manages eleven U.S. dollar–denominated funds and seven RMB-denominated funds, with total capital raised of approximately $9.5 billion. Since its establishment, Qiming Venture Partners has invested in a wide range of companies at the early and growth stages, and its partners regularly rank among the leaders of the global venture capital industry across multiple well-recognized rankings.
Qiming Venture Partners is committed to identifying companies with long-term potential and creating enduring value for society. Its investment team conducts in-depth research into industry trends, technological developments, and shifts in consumer behavior to identify emerging markets at an early stage. At the same time, the firm places strong emphasis on comprehensive and detailed due diligence, maintaining close engagement with entrepreneurs and conducting deep reviews of business operations and scientific data to assess opportunities and risks.
Focus is a core element of the firm’s investment philosophy. Qiming Venture Partners concentrates on industries it knows well, building deep insight and extensive networks within these sectors. By forming a connected ecosystem across its portfolio, the firm seeks to actively support companies after investment and help startups grow through multiple dimensions.
Since its inception, Qiming Venture Partners has engaged with tens of thousands of startup founding teams. On average, one out of every thirty companies reviewed receives funding, with approximately seventy percent of investments made at the Series A stage. Many portfolio companies have grown into industry leaders within seven years of investment.
In the healthcare sector, Qiming Venture Partners has invested in more than one hundred startups. Its healthcare portfolio spans diagnostics, research and development, medical equipment, and healthcare services, with increasing attention in recent years to AI-enabled digital healthcare opportunities.